{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:13:32Z","timestamp":1782400412653,"version":"3.54.5"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.1001\/jamainternmed.2024.1217","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T15:02:32Z","timestamp":1715007752000},"page":"847","source":"Crossref","is-referenced-by-count":1,"title":["Examining Safer Opioid Supply Policies"],"prefix":"10.1001","volume":"184","author":[{"given":"Hudson","family":"Reddon","sequence":"first","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-J.","family":"Milloy","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ile240012r1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamainternmed.2023.7570","article-title":"British Columbia\u2019s Safer Opioid Supply policy and opioid outcomes.","volume":"184","author":"Nguyen","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"9","key":"ile240012r5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.v114.9","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"key":"ile240012r2","volume-title":"A Review of Illicit Drug Toxicity Deaths","author":"British Columbia Coroners Service Death Review Panel","year":"2022"},{"key":"ile240012r4","volume-title":"Adulterants, Contaminants and Co-Occurring Substances in Drugs on the Illegal Market in Canada","author":"Payer","year":"2020"},{"key":"ile240012r3","unstructured":"Government of Canada. Opioid- and stimulant-related harms in Canada. 2023. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2818198\/jamainternal_reddon_2024_le_240012_1719497556.95269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:09:06Z","timestamp":1719846546000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2818198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.1217","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}